DIOR balloon new option for "untreatable" and high-risk PCI patients

A next-generation drug-eluting coronary balloon dilatation catheter could provide a new option for high-risk patients requiring percutaneous coronary intervention (PCI). It could treat patients immediately after they have suffered a heart attack, and could also be of benefit in patients with diabetes and renal disease. The DIOR paclitaxel-coated balloon, made by Eurocor of Bonn, Germany, also promises to reduce adverse coronary events and restenosis in some arteries versus conventional drug-eluting stents.

Category:

Science & Technology

Tags:

• DIOR
• PCI
• drug-eluting stent
• stent
• coronary balloon
• Eurocor
• restenosis
• diabetes
• renal disease
• heart attack
• clinica
• medical device